Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...

Some of the losses are down to pharma's broader problems: notably, President Trump's tariff and price-cut threats. But there ...

Scotland's cash-strapped NHS is now spending £10m a year on weight-loss injections - according to new figures that highlight ...

Mumbai: In a serious security and public health concern, several consignments of Novo Nordisk’s injectable medicines — ...